Burleson & Company, LLC Cortexyme, Inc. Transaction History

Burleson & Company, LLC

$384 Million
Q4 2022

A detailed history of Burleson & Company, LLC transactions in Cortexyme, Inc. stock. As of the latest transaction made, Burleson & Company, LLC holds 8,413 shares of CRTX stock, worth $10,852. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,413

Previous 303,918 97.23%

Holding current value

$10,852

Previous $404,000 97.52%

% of portfolio

0.0%

Previous 0.09%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	SELL	N/A	-295,505 Reduced 97.23%	8,413 $10,000
Q3 2022 Oct 17, 2022	BUY	$1.29 - $2.52 $56,462 - $110,297	43,769 Added 16.82%	303,918 $404,000
Q2 2022 Jul 13, 2022	BUY	$2.22 - $6.7 $78,921 - $238,185	35,550 Added 15.83%	260,149 $578,000
Q1 2022 Apr 25, 2022	BUY	$4.18 - $13.39 $35,488 - $113,681	8,490 Added 3.93%	224,599 $1.39 Million
Q4 2021 Jan 25, 2022	BUY	$11.35 - $97.17 $919,293 - $7.87 Million	80,995 Added 59.95%	216,109 $2.73 Million

Q3 2021 Nov 02, 2021	BUY	$52.0 - $120.21 $207,168 - $478,916	3,984 Added 3.04%	135,114 $12.4 Million
Q2 2021 Jul 22, 2021	BUY	$31.88 - $58.66 $349,086 - $642,327	10,950 Added 9.11%	131,130 $6.95 Million
Q1 2021 May 12, 2021	BUY	$28.6 - $49.21 $2.25 Million - $3.88 Million	78,803 Added 190.45%	120,180 $4.33 Million
Q4 2020 Feb 08, 2021	SELL	$27.78 - $56.93 $1.44 Million - $2.96 Million	-51,941 Reduced 55.66%	41,377 $1.15 Million
Q3 2020 Nov 10, 2020	BUY	$39.85 - $57.3 $1.56 Million - $2.24 Million	39,060 Added 71.99%	93,318 $4.48 Million
Q2 2020 Aug 13, 2020	BUY	$34.93 - $57.75 $771,953 - $1.28 Million	22,100 Added 68.72%	54,258 $2.39 Million
Q1 2020 May 15, 2020	BUY	$29.01 - $72.51 $692,758 - $1.73 Million	23,880 Added 288.48%	32,158 $1.48 Million
Q4 2019 Feb 12, 2020	BUY	$20.77 - $68.91 $171,934 - $570,436	8,278 New	8,278 $470,000

Others Institutions Holding CRTX

# of Institutions

Shares Held

7.27M

Call Options Held

103K

Put Options Held

View Full List

About Cortexyme, Inc.

Ticker CRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,150,800
Market Cap $70.5M

More about CRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Burleson & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Burleson & Company, LLC with notifications on news.

Account

Burleson & Company, LLC Cortexyme, Inc. Transaction History